The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: Notes from a recent workshop

Timothy M. Block, Jorge Marrero, Robert G. Gish, Morris Sherman, W. Thomas London, Sudhir Srivastava, Paul D. Wagner

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

This opinion piece evaluates the degree of readiness of 13 candidate biomarkers or panels of biomarkers for the early detection of hepatocellular carcinoma (HCC), or for the staging of liver fibrosis. As candidate biomarkers for the early detection of disease are identified, it is important to understand where they are in the developmental pipeline and how they might be employed. HCC is a growing public health problem, and its early detection is believed to be important in its management. Current detection methods are limited in usefulness or practicality, and there is a need for better methods to diagnose liver disease. Therefore, a number of candidate biomarkers, considered to be attractive because of their advanced stage of development or inherent scientific value, were evaluated for specificity and sensitivity for detection of liver disease. Study design, confirmatory evidence and assay practicality associated with each of the biomarkers are considered. The comments in this review reflect the authors' opinions and are based on a recent workshop convened by the Hepatitis B Foundation of America and the US National Cancer Institute's Early Detection Research Network. It is emphasized that only a selected set of biomarkers was considered; thus, this review is not comprehensive and not intended to review all candidate HCC biomarkers.

Original languageEnglish (US)
Pages (from-to)19-33
Number of pages15
JournalCancer Biomarkers
Volume4
Issue number1
StatePublished - 2008

Fingerprint

Hepatocellular Carcinoma
Biomarkers
Education
Liver Diseases
National Cancer Institute (U.S.)
Hepatitis B
Liver Cirrhosis
Early Diagnosis
Public Health
Sensitivity and Specificity
Research

Keywords

  • Biomarkers
  • Carcinoma
  • Cirrhosis
  • Fibrosis
  • Hepatocellular

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Genetics

Cite this

Block, T. M., Marrero, J., Gish, R. G., Sherman, M., London, W. T., Srivastava, S., & Wagner, P. D. (2008). The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: Notes from a recent workshop. Cancer Biomarkers, 4(1), 19-33.

The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma : Notes from a recent workshop. / Block, Timothy M.; Marrero, Jorge; Gish, Robert G.; Sherman, Morris; London, W. Thomas; Srivastava, Sudhir; Wagner, Paul D.

In: Cancer Biomarkers, Vol. 4, No. 1, 2008, p. 19-33.

Research output: Contribution to journalArticle

Block, TM, Marrero, J, Gish, RG, Sherman, M, London, WT, Srivastava, S & Wagner, PD 2008, 'The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: Notes from a recent workshop', Cancer Biomarkers, vol. 4, no. 1, pp. 19-33.
Block, Timothy M. ; Marrero, Jorge ; Gish, Robert G. ; Sherman, Morris ; London, W. Thomas ; Srivastava, Sudhir ; Wagner, Paul D. / The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma : Notes from a recent workshop. In: Cancer Biomarkers. 2008 ; Vol. 4, No. 1. pp. 19-33.
@article{f6794d7c557c45298c4422a8b322034f,
title = "The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: Notes from a recent workshop",
abstract = "This opinion piece evaluates the degree of readiness of 13 candidate biomarkers or panels of biomarkers for the early detection of hepatocellular carcinoma (HCC), or for the staging of liver fibrosis. As candidate biomarkers for the early detection of disease are identified, it is important to understand where they are in the developmental pipeline and how they might be employed. HCC is a growing public health problem, and its early detection is believed to be important in its management. Current detection methods are limited in usefulness or practicality, and there is a need for better methods to diagnose liver disease. Therefore, a number of candidate biomarkers, considered to be attractive because of their advanced stage of development or inherent scientific value, were evaluated for specificity and sensitivity for detection of liver disease. Study design, confirmatory evidence and assay practicality associated with each of the biomarkers are considered. The comments in this review reflect the authors' opinions and are based on a recent workshop convened by the Hepatitis B Foundation of America and the US National Cancer Institute's Early Detection Research Network. It is emphasized that only a selected set of biomarkers was considered; thus, this review is not comprehensive and not intended to review all candidate HCC biomarkers.",
keywords = "Biomarkers, Carcinoma, Cirrhosis, Fibrosis, Hepatocellular",
author = "Block, {Timothy M.} and Jorge Marrero and Gish, {Robert G.} and Morris Sherman and London, {W. Thomas} and Sudhir Srivastava and Wagner, {Paul D.}",
year = "2008",
language = "English (US)",
volume = "4",
pages = "19--33",
journal = "Cancer Biomarkers",
issn = "1574-0153",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma

T2 - Notes from a recent workshop

AU - Block, Timothy M.

AU - Marrero, Jorge

AU - Gish, Robert G.

AU - Sherman, Morris

AU - London, W. Thomas

AU - Srivastava, Sudhir

AU - Wagner, Paul D.

PY - 2008

Y1 - 2008

N2 - This opinion piece evaluates the degree of readiness of 13 candidate biomarkers or panels of biomarkers for the early detection of hepatocellular carcinoma (HCC), or for the staging of liver fibrosis. As candidate biomarkers for the early detection of disease are identified, it is important to understand where they are in the developmental pipeline and how they might be employed. HCC is a growing public health problem, and its early detection is believed to be important in its management. Current detection methods are limited in usefulness or practicality, and there is a need for better methods to diagnose liver disease. Therefore, a number of candidate biomarkers, considered to be attractive because of their advanced stage of development or inherent scientific value, were evaluated for specificity and sensitivity for detection of liver disease. Study design, confirmatory evidence and assay practicality associated with each of the biomarkers are considered. The comments in this review reflect the authors' opinions and are based on a recent workshop convened by the Hepatitis B Foundation of America and the US National Cancer Institute's Early Detection Research Network. It is emphasized that only a selected set of biomarkers was considered; thus, this review is not comprehensive and not intended to review all candidate HCC biomarkers.

AB - This opinion piece evaluates the degree of readiness of 13 candidate biomarkers or panels of biomarkers for the early detection of hepatocellular carcinoma (HCC), or for the staging of liver fibrosis. As candidate biomarkers for the early detection of disease are identified, it is important to understand where they are in the developmental pipeline and how they might be employed. HCC is a growing public health problem, and its early detection is believed to be important in its management. Current detection methods are limited in usefulness or practicality, and there is a need for better methods to diagnose liver disease. Therefore, a number of candidate biomarkers, considered to be attractive because of their advanced stage of development or inherent scientific value, were evaluated for specificity and sensitivity for detection of liver disease. Study design, confirmatory evidence and assay practicality associated with each of the biomarkers are considered. The comments in this review reflect the authors' opinions and are based on a recent workshop convened by the Hepatitis B Foundation of America and the US National Cancer Institute's Early Detection Research Network. It is emphasized that only a selected set of biomarkers was considered; thus, this review is not comprehensive and not intended to review all candidate HCC biomarkers.

KW - Biomarkers

KW - Carcinoma

KW - Cirrhosis

KW - Fibrosis

KW - Hepatocellular

UR - http://www.scopus.com/inward/record.url?scp=40449121005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40449121005&partnerID=8YFLogxK

M3 - Article

C2 - 18334731

AN - SCOPUS:40449121005

VL - 4

SP - 19

EP - 33

JO - Cancer Biomarkers

JF - Cancer Biomarkers

SN - 1574-0153

IS - 1

ER -